🔎 Trials Near Me

Avaleht › Müeloom › Rhode Island

Müeloom kliinilised uuringud osariigis Rhode Island

6 uuringut haiguse Müeloom jaoks otsivad osalejaid osariigis Rhode Island.

Linnad osariigis Rhode Island

Ametlik uuringutekst (inglise keeles)

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • Rhode Island Hospital, Providence
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT05552222

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • Rodhe Island Hospital, Providence
  • The Miriam Hospital, Providence
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. aug 2026 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
VärbamineFaas 3
Kõik vanused · Kõik sood · Uuendatud 10. juuni 2026 · NCT05561387

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  • GSK Investigational Site, Providence
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. apr 2026 · NCT06679101

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

  • Rhode Island Hospital, Providence
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. juuni 2025 · NCT06119685

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.